Why Emerge Gaming, Imugene, Mesoblast, & Nick Scali shares are dropping

These ASX shares are out of form on Thursday…

| More on:
white arrow pointing down

Image source: Getty Images

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.2% to 7,516.2 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping:

Emerge Gaming Ltd (ASX: EM1)

The Emerge Gaming share price has sunk 6% to 3.2 cents. This follows the embattled gaming company’s response to a series of questions by the Australian share market operator. In fact, the regulator sought answers for 14 questions. These were largely in relation to questionable statements included in recent announcements.

Imugene Limited (ASX: IMU)

The Imugene share price is down 3.5% to 28.5 cents. Investors have been selling the clinical stage immuno-oncology company’s shares despite it announcing an exclusive strategic partnership with Nasdaq-listed clinical-stage biotechnology company, Celularity. The two companies will work together to develop off-the-shelf placental-derived allogeneic therapies for the treatment of solid tumours.

Mesoblast limited (ASX: MSB)

The Mesoblast share price is down 3% to $1.96. This appears to have been driven by concerns over its cash burn. Research done by Ownership Matters, reported in the AFR, estimates that Mesoblast is close to recording $1 billion in cash outflows over the last decade. This has been spent on product development with little success to date.

Nick Scali Limited (ASX: NCK)

The Nick Scali share price has fallen 1% to $12.20. This furniture retailer’s shares have been bouncing around today following the release of its full year results. After initially hitting a record high, the company’s shares began to tumble. This was possibly due to concerns over its soft start to FY 2022 because of lockdowns. It was for this reason that management was unable to provide guidance for the year ahead.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News